Furthermore, MACC1 has been recognized as a prognostic, predictive, and causative biomarker in more than 20 different cancer entities, including CRC, lung cancer, and gastric cancer making it a promising molecular target for solid cancers. This evidence concerns the gene MACC1 and colorectal carcinoma.